Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Ratio (2020 - 2025)

Celularity (CELU) has disclosed Equity Ratio for 6 consecutive years, with 0.35 as the latest value for Q4 2025.

  • For Q4 2025, Equity Ratio fell 632.45% year-over-year to 0.35; the TTM value through Dec 2025 reached 0.35, down 632.45%, while the annual FY2025 figure was 0.35, 632.45% down from the prior year.
  • Equity Ratio hit 0.35 in Q4 2025 for Celularity, down from 0.18 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.5 in Q4 2022 and bottomed at 5.05 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.2, with a median of 0.21 recorded in 2022.
  • Year-over-year, Equity Ratio surged 119.47% in 2021 and then tumbled 632.45% in 2025.
  • Celularity's Equity Ratio stood at 0.24 in 2021, then skyrocketed by 106.58% to 0.5 in 2022, then crashed by 42.6% to 0.28 in 2023, then tumbled by 76.6% to 0.07 in 2024, then plummeted by 632.45% to 0.35 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.35, 0.18, and 0.21 for Q4 2025, Q3 2025, and Q2 2025 respectively.